Molecular docking and machine learning analysis of Abemaciclib in colon cancer
Abstract Background The main challenge in cancer research is the identification of different omic variables that present a prognostic value and personalised diagnosis for each tumour. The fact that the diagnosis is personalised opens the doors to the design and discovery of new specific treatments f...
Main Authors: | Jose Liñares-Blanco, Cristian R. Munteanu, Alejandro Pazos, Carlos Fernandez-Lozano |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Molecular and Cell Biology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12860-020-00295-w |
Similar Items
-
In silico drug repurposing: An antifungal drug, itraconazole, repurposed as an anticancer agent using molecular docking
by: Sanika Dhorje, et al.
Published: (2020-01-01) -
Revisiting Activity of Some Nocodazole Analogues as a Potential Anticancer Drugs Using Molecular Docking and DFT Calculations
by: Muhammad Khattab, et al.
Published: (2021-03-01) -
Density Functional Theory Studies and Molecular Docking on Xanthohumol, 8-Prenylnaringenin and Their Symmetric Substitute Diethanolamine Derivatives as Inhibitors for Colon Cancer-Related Proteins
by: Manos C. Vlasiou, et al.
Published: (2021-05-01) -
High expression of FABP4 and FABP6 in patients with colorectal cancer
by: Yaqin Zhang, et al.
Published: (2019-10-01) -
Molecular Docking: Shifting Paradigms in Drug Discovery
by: Luca Pinzi, et al.
Published: (2019-09-01)